Encompass Health Pre-Tax Profit Margin 2010-2024 | EHC

Current and historical pre-tax profit margin for Encompass Health (EHC) from 2010 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Encompass Health pre-tax profit margin for the three months ending March 31, 2024 was .
Encompass Health Pre-Tax Profit Margin Historical Data
Date TTM Revenue TTM Pre-Tax Income Pre-Tax Margin
2024-03-31 $4.96B $0.64B 12.89%
2023-12-31 $4.80B $0.61B 12.64%
2023-09-30 $4.69B $0.59B 12.64%
2023-06-30 $4.57B $0.56B 12.13%
2023-03-31 $4.45B $0.49B 10.94%
2022-12-31 $4.35B $0.45B 10.37%
2022-09-30 $3.70B $0.33B 8.87%
2022-06-30 $3.62B $0.35B 9.64%
2022-03-31 $3.84B $0.45B 11.65%
2021-12-31 $4.02B $0.51B 12.58%
2021-09-30 $3.67B $0.51B 13.83%
2021-06-30 $3.83B $0.51B 13.22%
2021-03-31 $3.61B $0.38B 10.63%
2020-12-31 $3.57B $0.35B 9.90%
2020-09-30 $4.61B $0.44B 9.56%
2020-06-30 $4.60B $0.47B 10.17%
2020-03-31 $4.66B $0.54B 11.64%
2019-12-31 $4.61B $0.56B 12.25%
2019-09-30 $4.52B $0.52B 11.56%
2019-06-30 $4.42B $0.51B 11.49%
2019-03-31 $4.36B $0.52B 11.82%
2018-12-31 $4.28B $0.49B 11.55%
2018-09-30 $4.19B $0.55B 13.22%
2018-06-30 $4.11B $0.54B 13.20%
2018-03-31 $4.00B $0.51B 12.69%
2017-12-31 $3.91B $0.50B 12.67%
2017-09-30 $3.84B $0.48B 12.56%
2017-06-30 $3.77B $0.47B 12.58%
2017-03-31 $3.71B $0.49B 13.22%
2016-12-31 $3.64B $0.48B 13.26%
2016-09-30 $3.58B $0.47B 13.15%
2016-06-30 $3.43B $0.45B 13.20%
2016-03-31 $3.28B $0.42B 12.90%
2015-12-31 $3.12B $0.40B 12.71%
2015-09-30 $2.86B $0.36B 12.63%
2015-06-30 $2.68B $0.35B 12.92%
2015-03-31 $2.52B $0.38B 15.20%
2014-12-31 $2.38B $0.39B 16.29%
2014-09-30 $2.34B $0.41B 17.47%
2014-06-30 $2.30B $0.43B 18.58%
2014-03-31 $2.27B $0.39B 17.17%
2013-12-31 $2.25B $0.40B 17.58%
2013-09-30 $2.23B $0.38B 17.17%
2013-06-30 $2.20B $0.36B 16.51%
2013-03-31 $2.17B $0.35B 16.33%
2012-12-31 $2.14B $0.34B 15.93%
2012-09-30 $2.09B $0.34B 16.31%
2012-06-30 $2.06B $0.30B 14.76%
2012-03-31 $2.04B $0.26B 12.91%
2011-12-31 $2.01B $0.24B 12.16%
2011-09-30 $1.95B $0.20B 10.48%
2011-06-30 $1.91B $0.19B 9.95%
2011-03-31 $1.87B $0.20B 10.74%
2010-12-31 $1.86B $0.19B 10.21%
2010-09-30 $1.78B $0.16B 9.16%
2010-06-30 $1.79B $0.16B 8.78%
2010-03-31 $1.80B $0.11B 5.88%
2009-12-31 $1.79B $0.11B 5.99%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $8.507B $4.801B
Encompass Health Corporation is a provider of integrated healthcare services. It offers both facility-based and home-based patient care through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The company delivers high-quality, cost-effective, integrated care in the healthcare space. It provides a continuum of facility-based and home-based post-acute services for its patients and their families, which will gain more prevalence as coordinated care and integrated delivery payment models, such as accountable care organizations and bundled payment arrangements. The company operates through two segments: Inpatient Rehabilitation as well as Home Health and Hospice business.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $17.537B 10.61
Quest Diagnostics (DGX) United States $15.695B 16.22
DaVita (DVA) United States $12.150B 15.09
Chemed (CHE) United States $8.408B 26.06
Elanco Animal Health (ELAN) United States $8.297B 21.53
Option Care Health (OPCH) United States $5.048B 19.11
RadNet (RDNT) United States $4.325B 90.06
Amedisys (AMED) United States $3.145B 22.28
Astrana Health (ASTH) United States $2.239B 30.28
LifeStance Health (LFST) United States $2.179B 0.00
Addus HomeCare (ADUS) United States $1.827B 26.14
U.S Physical Therapy (USPH) United States $1.534B 41.06
Pennant (PNTG) United States $0.706B 37.29
Aveanna Healthcare Holdings (AVAH) United States $0.539B 0.00
Atai Life Sciences (ATAI) Germany $0.270B 0.00
Daxor (DXR) United States $0.045B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.026B 0.00
ATI Physical Therapy (ATIP) United States $0.021B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Ontrak (OTRK) United States $0.013B 0.00
Novo Integrated Sciences (NVOS) United States $0.010B 0.00
IMAC Holdings (BACK) United States $0.004B 0.00